LV14461A - Preparation that effectively reduces high glutamate level in blood - Google Patents

Preparation that effectively reduces high glutamate level in blood

Info

Publication number
LV14461A
LV14461A LVP-11-117A LV110117A LV14461A LV 14461 A LV14461 A LV 14461A LV 110117 A LV110117 A LV 110117A LV 14461 A LV14461 A LV 14461A
Authority
LV
Latvia
Prior art keywords
blood
preparation
effectively reduces
reduces high
glutamate level
Prior art date
Application number
LVP-11-117A
Other languages
Latvian (lv)
Other versions
LV14461B (en
Inventor
Vladimirs Voicehovskis
Jūlija VOICEHOVSKA
Gunta ANCĀNE
Andrejs ŠĶESTERS
Grigorijs ORĻIKOVS
Original Assignee
Paula Stradiņa Klīniskā Universitātes Slimnīca, Vsia
Rīgas Stradiņa Universitāte
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Paula Stradiņa Klīniskā Universitātes Slimnīca, Vsia, Rīgas Stradiņa Universitāte filed Critical Paula Stradiņa Klīniskā Universitātes Slimnīca, Vsia
Priority to LVP-11-117A priority Critical patent/LV14461B/en
Publication of LV14461A publication Critical patent/LV14461A/en
Priority to PCT/LV2012/000001 priority patent/WO2013039367A1/en
Publication of LV14461B publication Critical patent/LV14461B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4875—Compounds of unknown constitution, e.g. material from plants or animals

Abstract

An invention relates to the field of medicine.The proposed preparation is a composition containing selenium and vitamin E. The composition reduces glutamate level in blood.
LVP-11-117A 2011-09-15 2011-09-15 Preparation that effectively reduces high glutamate level in blood LV14461B (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
LVP-11-117A LV14461B (en) 2011-09-15 2011-09-15 Preparation that effectively reduces high glutamate level in blood
PCT/LV2012/000001 WO2013039367A1 (en) 2011-09-15 2012-02-01 Preparation that effectively reduces high glutamate level in blood

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LVP-11-117A LV14461B (en) 2011-09-15 2011-09-15 Preparation that effectively reduces high glutamate level in blood

Publications (2)

Publication Number Publication Date
LV14461A true LV14461A (en) 2012-01-20
LV14461B LV14461B (en) 2012-07-20

Family

ID=47883509

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-11-117A LV14461B (en) 2011-09-15 2011-09-15 Preparation that effectively reduces high glutamate level in blood

Country Status (2)

Country Link
LV (1) LV14461B (en)
WO (1) WO2013039367A1 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6444221B1 (en) * 1992-06-30 2002-09-03 Howard K. Shapiro Methods of treating chronic inflammatory diseases using carbonyl trapping agents
GB9722361D0 (en) * 1997-10-24 1997-12-17 Pharma Nord Uk Ltd Pharmaceutical formulation for treating liver disorders
RU2222996C1 (en) * 2002-07-02 2004-02-10 Прокопенко Юрий Иванович Biologically active food additive

Also Published As

Publication number Publication date
LV14461B (en) 2012-07-20
WO2013039367A1 (en) 2013-03-21

Similar Documents

Publication Publication Date Title
MX338515B (en) Tetrahydroquinoline derivatives useful as bromodomain inhibitors.
GB201316021D0 (en) Vitamin D composition
IN2014DN10386A (en)
TN2013000310A1 (en) Effervescent composition in solid form for use in vaginal applications for the treatment of vaginal infections
SG178991A1 (en) Anti-gitr antibodies
JOP20180104A1 (en) Aryl- or heteroaryl-substituted benzene compounds
CL2014001345A1 (en) Methods of treatment using an antibody against interferon gamma; Uses pharmaceutical composition containing an antibody against interferon gamma.
MX2012007806A (en) Pharmaceutical compositions for oral administration of insulin peptides.
MX2015002669A (en) Methods of administering pirfenidone therapy.
IN2014DN08215A (en)
MX2016008226A (en) Prebiotic oral care methods using a saccharide.
PH12017501688A1 (en) Intranasal benzodiazepine pharmaceutical compositions
CO7160080A2 (en) Lipid compositions of racecadot
MX2015007164A (en) Use of fenugreek extract to enhance female libido.
GB201317815D0 (en) Oral supplementation for the reversal of human hair canities
JO3688B1 (en) Pharmaceutical composition in the form of an oral suspension comprising a flavonoid fraction and xanthan gum
IN2014DN03010A (en)
MX2014006201A (en) Imatinib solid dosage forms reconstituted just before use.
LV14461A (en) Preparation that effectively reduces high glutamate level in blood
MX2015013160A (en) Method and products for enhancing cellular uptake of drug and dietary supplements.
UA66925U (en) orthopedic spinal support
NZ723918A (en) Methods for improving diaphragm function
IN2013DE02372A (en)
EA201201219A1 (en) PHARMACEUTICAL COMPOSITION, HAVING METABOLIC, ANTI-PATH, RETINOPROTECTIVE ACTION (OPTIONS)
UA101935C2 (en) method for hair biolamination by indrikson